UK Supreme Court shoots down NHS £220m drug patent suit

02-07-2021

Alex Baldwin

UK Supreme Court shoots down NHS £220m drug patent suit

marbury / Shutterstock.com

The UK Government has failed to convince UK Supreme Court judges that Servier Laboratories misrepresented its blood pressure drugs patent in legal proceedings to block generic competitors from entering the market.


UK Supreme Court, Servier Laboratories, generics

LSIPR